ICEC0942 (CT7001)

CAS: 1805789-54-1

Ref. 3D-FXC78954

Produktinformation

• Name: ICEC0942 (CT7001)
• Synonyme: Samuraciclib Hydrochloride, (3R,4R)-4-(((7-(Benzylamino)-3-isopropylpyrazolo[1,5-a]pyrimidin-5-yl)amino)methyl)piperidin-3-olhydrochloride, 3-Piperidinol, 4-3-(1-methylethyl)-7-(phenylmethyl)aminopyrazolo1,5-apyrimidin-5-ylaminomethyl-, hydrochloride (1, 1), (3R,4R)-, CT7001 hydrochloride, Samuraciclib hydrochloride, ICEC0942;ICE C0942;ICE-C0942;CT7001;CT-7001;CT 7001, PPDA-001 HCL SALT, ICEC 0942 hydrochloride, 3-Piperidinol, 4-[[[3-(1-methylethyl)-7-[(phenylmethyl)amino]pyrazolo[1,5-a]pyrimidin-5-yl]amino]methyl]-, hydrochloride (1:1), (3R,4R)-

Beschreibung

ICEC0942 is a protein kinase inhibitor that inhibits the activity of transcription factors. It has been shown to have anticancer effects in laboratory studies and in clinical trials on patients with cancer. ICEC0942 was found to be effective at a dose of 0.3 mg/kg, which is lower than the doses typically used for chemotherapy drugs. ICEC0942 also has a low toxicity profile and does not cause DNA damage or cellular dysregulation, which are common side effects of other cancer therapies.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 430.97 g/mol
• Formel: C₂₂H₃₁ClN₆O
• Reinheit: Min. 95%